Bioanalytical Community

 View Only

[June 13TH] Critical Reagents Working Group Monthly Meeting "ADA Assessment for Oligonucleotide-based Therapeutics in Non-clinical and Clinical Studies" (Meeting Details Included)

  • 1.  [June 13TH] Critical Reagents Working Group Monthly Meeting "ADA Assessment for Oligonucleotide-based Therapeutics in Non-clinical and Clinical Studies" (Meeting Details Included)

    Posted 06-06-2025 12:19

    The June meeting of the Critical Reagent's working group will be next Friday June 13th at 12 Noon EDT (Details below). 

    we will have the pleasure of hosting Susovan Mohapatra from Stoke Therapeutics who will present on 'ADA Assessment for Oligonucleotide-based Therapeutics in Non-clinical and Clinical Studies'. During this presentation he will focus on case studies highlighting ADA positive control generation, and ADA assay development for ASOs.

    Additionally, we will also have an update on the white paper regarding the COAs for critical reagents.

    ________________________________________________________________________________

    Microsoft Teams https://aka.ms/JoinTeamsMeeting?omkt=en-US. Click or tap if you trust this link." data-ogsc="">Need help?

    Meeting ID: 248 181 224 181

    Passcode: N9Lp9QW2


    Dial in by phone

    +1 323-676-6166,,883829066# United States, Los Angeles

    Phone conference ID: 883 829 066#

    For organizers: 19_meeting_NzBhYjg0NzEtNGQ0Yy00MmRmLWExMzItNGQyNTFhMGFkYjJj@thread.v2&messageId=0&language=en-US" title="https://teams.microsoft.com/meetingOptions/?organizerId=c9a417d0-425a-4ae1-a986-f48b68551072&tenantId=acad3d18-f637-4e09-8524-cb54146e0f3a&threadId=19_meeting_NzBhYjg0NzEtNGQ0Yy00MmRmLWExMzItNGQyNTFhMGFkYjJj@thread.v2&messageId=0&language=en-US" data-ogsc="">Meeting options | Reset dial-in PIN

    ________________________________________________________________________________

     



    ------------------------------
    Scott Robotham, Ph.D.
    Senior Principal Scientist
    Bristol Myers Squibb
    Princeton, NJ
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------